Telemetry Investments’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Telemetry Investments’s Portfolio OREX Stock Details OREX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-25,000	Closed	-$1.24M	–	217
2015 Q2	$1.24M	Buy	25,000 +20,000	+400%	+$1.2M	0.56%	43
2015 Q1	$392K	Buy	+5,000	New	+$310K	0.22%	90

Other funds holding OREX

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Telemetry Investments's OREX Position: Q2 2018 in Review

Telemetry Investments sold out of Orexigen Therapeutics, Inc. (OREX) in Q2 2018, closing a stake of 50,000 shares — an estimated $10K sold.

Telemetry Investments first reported a position in OREX in Q4 2014 and held it in 13 quarters. The position peaked at $3.63M in Q1 2015. 4 funds tracked by Wall St. Rank hold OREX as of Q2 2018.

Telemetry Investments reported no remaining Orexigen Therapeutics, Inc. position as of Q2 2018 after selling out during the quarter.
Telemetry Investments sold 50,000 Orexigen Therapeutics, Inc. shares in Q2 2018, an estimated $10K.
Telemetry Investments first reported a position in Orexigen Therapeutics, Inc. in Q4 2014 and held it in 13 quarters.
Telemetry Investments's Orexigen Therapeutics, Inc. position peaked at $3.63M in Q1 2015.
4 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q2 2018.

Based on Telemetry Investments's 13F filing for Q2 2018, filed 14 Aug 2018.